Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site’s revision metadata was updated from v3.5.4 to v3.5.5, signaling a new build of the page template. This update does not change the study data or content on the page.
    Difference
    0.0%
    Check dated 2026-06-08T23:07:48.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The study location listing for Kharkiv has been updated from Kharkivs’ka Oblast’ and the old city/address line to Kharkiv Oblast and Kharkiv, Kharkiv Oblast, Ukraine, 61024.
    Difference
    0.0%
    Check dated 2026-06-01T19:22:44.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A new PubMed citation about patient-reported outcomes from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial has been added to the Publications section. A note clarifies that these publications are automatically filled from PubMed and may not all be about the study.
    Difference
    0.1%
    Check dated 2026-05-25T16:41:07.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.3 to v3.5.4, indicating a minor maintenance update to the study record page.
    Difference
    0.0%
    Check dated 2026-05-18T13:01:17.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added Taoyuan, Taiwan, 333 to the study locations and removed Taoyuan District, Taiwan, 333 from the list, updating the Taiwan sites to reflect a city-level entry.
    Difference
    0.0%
    Check dated 2026-05-04T05:54:35.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    This update reflects a background change to the ClinicalTrials.gov page revision/version number, with no visible change to the study’s substantive content.
    Difference
    0.0%
    Check dated 2026-04-27T07:49:35.000Z thumbnail image

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.